STATE LAWS AND BIOSIMILARS
Find Out More About the Increasing Number of States Passing Laws Regarding the Substitution of Biosimilars
POLICIES TO LOWER HEALTH CARE COSTS WITH BIOSIMILARS
Congress must continue to pursue common sense, bipartisan policy solutions that will help increase access for patients and encourage physicians to offer safe, FDA-approved, and lower-cost biosimilars.
SIGNIFICANT HEALTHCARE SAVINGS POSSIBLE IF U.S. CULTIVATES A ROBUST BIOSIMILARS MARKET
New Biosimilars Forum and Medicines for Europe research details how the EU created a competitive, multisource biosimilars market that increases patient access, creates cost-savings
THE BASIC FACTS ABOUT BIOSIMILARS
Find Out More About the Basic Science Around Biosimilars
STAY CONNECTED
Get information and updates from the Biosimilars Forum
EDUCATIONAL RESOURCES
Check out our downloadable resources
BIOSIMILAR BASICS FOR PATIENTS (FDA)
Biosimilars are FDA-approved biologic medications that are compared to another medication – the original biologic.
- Same expected benefits and risks
- Access
- Safe and effective
- Frequently asked questions